[Prophylaxis using quinolones in neutropenic patients. Preliminary results of a cooperative study by the Grupo Italiano Malattie Ematologiche maligne dell'adulto (GIMEMEA)].
Del Favero
A
A
Martino
P
P
Bucaneve
G
G
Micozzi
A
A
D'Antonio
D
D
Minetti
B
B
Ricci
P
P
Landonio
G
G
Montillo
M
M
Malleo
C
C
D000380:Agranulocytosis / Q000150:complications*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000209:etiology / Q000517:prevention & control*; D016026:Bone Marrow Transplantation / Q000009:adverse effects; D002939:Ciprofloxacin / Q000627:therapeutic use*; D004198:Disease Susceptibility; D005260:Female; D006801:Humans; D007938:Leukemia / Q000150:complications / Q000601:surgery; D008297:Male; D015337:Multicenter Studies as Topic; D009503:Neutropenia / Q000150:complications*; D009643:Norfloxacin / Q000627:therapeutic use*; D011446:Prospective Studies; D011897:Random Allocation
D000900:Anti-Bacterial Agents; D002939:Ciprofloxacin; D009643:Norfloxacin
Profilassi con chinoloni in pazienti neutropenici. Risultati preliminari di uno studio cooperativo del Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA).